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In the crystal structure of the reduced form of the wild-type human peroxiredoxin 5, the presence of a benzoate 
ion in direct interaction with the peroxidatic cysteine (Cys 47) appeared as a rather intriguing feature since it is 
known that the benzoate ion can play the role of a specific hydroxyl radical scavenger. The crystal structure of 
the C47S mutant of the same enzyme has been crystallized in the tetragonal system, space group P41212, with a 
= 65.65 Å, c = 122.04 Å. It confirms the presence of this benzoate ion in spite of the mutation into a serine of the 
Cys 47 residue to which the benzoate ion was directly linked in the wild-type structure. The benzoate ion seems 
to be stabilized by hydrophobic contacts on both sides of the aromatic ring. In this matter, the α5 helix, which is 
specific to peroxiredoxin 5 among mammalian peroxiredoxins, plays an important role. These hydrophobic 
contacts also allow to suggest why the benzoate ion disappears when the molecule is oxidized. 
Keywords : Antioxidant enzyme ; peroxiredoxin ; thioredoxin fold ; thioredoxin peroxidase. 
 
INTRODUCTION 
The peroxiredoxins (PRDXs) define a large family of peroxidases able to reduce hydrogen peroxide and alkyl 
hydroperoxides from prokaryotes to eukaryotes.
1-3
 Functionally, PRDXs have been implicated in antioxidant 
protection and regulation of redox-dependent signaling in cells. Structurally, all PRDXs contain a conserved 
peroxidatic Cys residue in the N-terminal portion of the protein, that attacks the peroxide and is oxidized to Cys 
sulfenic acid. PRDXs are classified into three subgroups depending on the number of Cys residues directly 
involved in catalysis and on the resolution mechanism of the Cys sulfenic acid. PRDX1-PRDX4 represent the 
typical 2-Cys mammalian subgroup and are obligate homodimers. In this subgroup, the N-terminal Cys residue 
(Cys51 in human PRDX2) oxidized to sulfenic acid is attacked by the resolving Cys (Cys 172 in human PRDX2) 
located in the C-terminus of the other subunit resulting in the formation of an intermolecular disulfide bond. 
PRDX5 is the only identified mammalian member of the atypical 2-Cys subgroup. In atypical 2-Cys PRDXs, the 
C-terminal resolving Cys is contained in the same protein and the reaction with the peroxidatic Cys results in the 
formation of an intramolecular disulfide bond. Finally, PRDX6 is classified in the mammalian 1-Cys subgroup in 
which the N-terminal peroxidatic Cys (Cys47) is conserved and the resolving C-terminal Cys is missing. 





represents the mammalian 1-Cys subgroup for which a crystal structure is also available.
7
 In typical 2-Cys and 1-
Cys subgroups, the crystal structures are characterized by the formation of tightly associated dimers resulting 
from the association of the β sheets of two monomers to form a 10- or 14-stranded β-sheet. PRDX5, the 
mammalian atypical 2-Cys PRDX, was characterized
8,9
 and the structure of its reduced state was recently solved 
by our group in two different crystal forms.
10,11
 Another crystal form simultaneously containing the reduced state 
and an unexpected dimeric oxidized state was also described.
12
 All the reduced molecules show that the sulfur 
atoms of Cys47 and Cys151 are positioned too far apart (13.8 Å) to interact in the expected intramolecular way 
without large conformational changes. The dimer present in all other known PRDXs structures and resulting 
from the association of β sheets is not observed in PRDX5. Also, the crystal structure of the reduced form of 
PRDX5 allowed to discover the presence of a benzoate ion, a specific scavenger of hydroxyl radical,
13
 covering 
the active site pocket and interacting with the sulfur atom of the conserved peroxidatic cysteine residue (Cys47). 
Since the mutation of the peroxidatic Cys47 into a Ser residue (C47S) in human PRDX5 inhibits its peroxidase 
activity
9
 and its antioxidant protection in vitro and in vivo,
14
 and since benzoate ion known as a scavenger of 
hydroxyl radical was directly linked to Cys 47 residue in the wild-type structure, additional structural 
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investigations were necessary to determine whether a loss of antioxidant activity of human PRDX5 C47S mutant 
could only be due to the replacement of the catalytic Cys by a Ser or also to conformational changes leading to 
the release of the benzoate ion. 
Here we present the crystal structure analysis of human PRDX5 C47S mutant. The crystal structure refined at 1.7 
Å shows the presence of the benzoate ion in spite of the mutation of Cys47 into a Ser. The benzoate ion appears 
to be stabilized by hydrophobic contacts on both sides of the aromatic ring. 
EXPERIMENTAL SECTION 
The expression and purification of wild-type human PRDX5 and mutant C47S were previously described.
10,14
 
The crystals of the 6xHis-tagged molecule were grown in reducing conditions by hanging or sitting drop vapour 
diffusion at 18°C with the well solution (500 µL) consisting of 1.6 M ammonium sulfate and 0.2 M potassium 
sodium tartrate as precipitant, 0.1 M sodium citrate buffer pH 5.3, 10
-3
 M 1,4-dithio-dl-threitol as antioxidant and 
0.02% (w/v) sodium azide. The crystallization drop was formed by mixing equal amounts (2-10 µL) of the 
protein solution (10 mg mL
-1
) and of the well solution. 
Before data collection, the crystal was cryo-soaked for a few seconds in paratone and flash cooled at 100 K. Data 
were collected at 1.7 Å resolution on the synchrotron BW7A beam line at EMBL c/o DESY using a MAR-ccd 
detector. The images were processed with the program DENZO
15
 and merged with the program SCALEPACK.
15
 
The crystals are tetragonal, space group P41212, with a = 65.65 Å, c = 122.04 Å, and one protein molecule in the 
asymmetric unit. Five percent of the reflections were flagged for use in Rfree calculations.
16
 Some statistics of 
data collection and processing are presented in Table 1. 
Since the space group and the cell dimensions of the C47S mutant of PRDX5 allowed to suppose a probable 
isomorphism with the tetragonal structure of the wild-type enzyme
10
 (pdb entry 1hd2), these coordinates were 
used for starting the refinement after applying the appropriate mutation. A rigid body refinement using 
REFMAC5
17
 belonging to the CCP4 suite
18
 yielded values of 0.343 and 0.348 for R and Rfree, respectively. Some 
minor adjustments were performed with O
19
 and were followed by cycles of refinement with REFMAC5. The N-
terminal His tag and the short linker were not observed except for the last residue (Ser 0). Electron density for a 
benzoate ion was apparent in the initial electron density map despite its absence in the initial model used for 
phasing. Solvent molecules were progressively introduced by ARP/wARP.
20
 A significant improvement was 
reached by refining the mean square displacements of the unique molecule considered as a rigid body and 
defined as a TLS group. It was necessary to introduce alternate conformations for a number of side chains, 
mainly located at the surface of the molecule: Glu13, Glu18, Asn21, Glu27, Glu57, Gln68, Ser74, Glu83, Lys89, 
Glu91, Asp114, Ser159. The final R value is 0.146 (Rfree = 0.169) for a model containing 3 chloride ions and 285 
solvent molecules. 
 
Table 1. Statistics of Data Collection and Refinement 
Wavelength (Å)  0.9911 
Resolution (Å) Overall (ov) 37-1.70 
 Highest shell (hs) 1.74-1.70 
Measured reflections  184,830 
Unique reflections  30,149 
Completeness (%) ov/hs 99.8/100 
Rsym ov/hs 0.053/0.292 
I/σ(I)  ov/hs 32/5.5 
Refinement   
R factor (Rfree) Overall 0.146 (0.169) 
Highest shell 0.179 (0.171) 
Estimated overall coordinate error (Å) Based on Rfree 0.068 
Based on maximum likelihood 0.040 
r.m.s. deviations from ideality Bonds (Å) 0.019 
Angles (°) 1.63 
r.m.s. deviations in B values (bonded atoms) (Å
2
) Main chain 0.82 
Side chain 2.44 
Mean B values (Å
2
) before TLS refinement Main-chain atoms 20.4 
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Side-chain atoms 23.2 
Solvent molecules 40.5 
Chloride ions 25.4 
Benzoate ion 19.9 
Ramchandran plot: non-glycine residues located in The most favored regions 89.4% 
Disallowed regions None 
 
RESULTS AND DISCUSSION 
All the 161 residues of the protein are well defined in the electron density. As shown in Fig. 1, the overall 
structure is characterized by the presence of a thioredoxin fold consisting of a four-stranded β sheet and three 
flanking α helices23 and the benzoate ion remains present at the surface of the active site pocket. Each molecule 
comprises three additional α helices and three β strands, one of which is associated with the thioredoxin β sheet 
to form a fifth strand while the two remaining ones form an additional two stranded β sheet in the N-terminal 
part of the molecule. Since the overall folding is very similar to that described for the two crystal forms of the 
wild PRDX5 structures,
10,11 
it will not be further discussed. 
In the tetragonal (1hd2) structure of the reduced wild-type PRDX5 enzyme, the presence of a benzoate ion 
located at the surface of the active site pocket
10
 appears as a completely unexpected structural feature. This ion 
was also found in the monoclinic structure (1h4o)
11
 for each of the eight independent molecules of the 
asymmetric unit. As benzoate is known to be a specific hydroxyl radical scavenger, its presence close to the 
active site might not be fortuitous. The present study confirms the presence of the benzoate ion (Fig. 1) in the 
C47S mutant. In lhd2, the distance between the oxygen atom O1 of the benzoate ion and the sulfur atom of 
Cys47 is 3.4 Å and we now observe a distance of 2.92 Å with the O
γ
 atom of Ser47, confirming the presence of a 
hydrogen bond between the two oxygen atoms. Other distances involving the carboxylate oxygen atoms of the 
benzoate ion are compared in Table 2a and show that in the C47S mutant this part of the benzoate is even better 
anchored to the active site pocket than in the wild-type enzyme. 
 
Fig. 1. The structure of the C47S mutant of human peroxire-doxin 5. The structural elements representative of 
the thiore-doxin fold are colored green (helices) and red (sheets). The benzoate ion and the side chains of some 
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Table 2. Distances (Å) Involving Atoms of the Benzoate Ions 
 C47S mutant Wild type 





 3.07 3.38 
 Gly46 N 3.26 3.01 





 2.92 3.40 
 Arg127N
ε2
 2.79 2.99 
Benzoate O
2
 Gly46 N 2.67 2.68 










 3.99 3.87 
 Phe120 C
δ





 3.62 3.66 
Note. Comparison of the distances observed in the C47S mutant and in the wild-type enzyme (lhd2). 
 
The presence of a benzoate ion in contact with the active site residues has already been described in the crystal 
structure of chloroper-oxidase from S. aureofaciens Tü24 (pdb entry 1a8u).
24
 An organic acid is required in this 
enzyme for the haloperoxidase activity. The complex with benzoate was obtained after soaking the crystals in a 
solution containing sodium benzoate. However, the benzoate is not specific since complexes were also obtained 
with propionate and acetate. In these complexes, both carboxyl oxygen atoms of the organic acids are within 
hydrogen bonding distance from Ser98 O
γ
. Interestingly, these carboxyl oxygen atoms are also hydrogen bound 
to backbone nitrogen atoms, to His257 N
ε2
 belonging to the active site and to a Thr O
γ
. Table 2a shows that this 
situation is very similar to our observations in PRDX5 (wild-type and C47S mutant) with the replacement of 
His257 N
ε2




 interacts with the S
γ
 atom of Cys47 (wild-type) or the O
γ
 atom of Ser47 
(mutant). In PRDX5, it is however worth remembering that the benzoate ion was not added at any stage of the 
production, of the purification, or of the crystallization. However, we cannot completely exclude that the 
benzoate ion was present in bacterial culture media (LB Broth base including peptone 140 and yeast extract) 
used in the production of E. coli recombinant human PRDX5. The remaining contacts of the benzoate ion in 
PRDX5 involve its aromatic part and are thus mainly hydrophobic. The buried surfaces of the protein by the 
presence of this aromatic ring are very similar in the cases of the C47S mutant and of the wild-type enzyme, 
respectively 47 Å
2
 in the C47S mutant compared to 52 Å
2
 in the wild-type enzyme. These hydrophobic contacts 
between the protein and the benzoate ion concern four residues at the level of the protein and the shortest 
distances between these residues and the aromatic ring are given in Table 2b. As shown in Fig. 1, one residue, 
Thr147, appears on one face of the aromatic ring. 
The three remaining residues (Leu116, Ile119, and Phe120), located on the other face, belong to the α5 helix 
which is a characteristic of PRDX5, since it is not present in other PRDXs structures. This α5 helix which 
appears as a bump at the surface of the protein thus seems to be an essential feature for holding the benzoate ion 
in its position. It constitutes one side of a kind of pincer in which the benzoate is locked, the other side being the 
Thr147 residue. When PRDX5 is oxidized, it was shown
12
 that the region 146-147 undergoes an important 
reorganization in order to bring the resolving residue Cys151 in the neighborhood of the peroxidatic residue 
Cys47 and to allow the formation of the disulfide bond. During this movement, one side of the pincer (Thr147) is 
thus relaxed and the benzoate ion can escape from the trap. From the comparison of nine independent molecules 
of PRDX5, the region of residues 146-147 was also recognized for its important flexibility.
11
 
Interestingly, it was previously noticed
12 that the α5 helix was involved in the formation of a non-covalent dimer 
between two PRDX5 molecules. This kind of dimer buries about 790 Å
2 
per molecule and since it is present in 
structures of reduced and oxidized forms of PRDX5 belonging to different space groups and systems (tetragonal 
for 1hd2,
10
 monoclinic for 1h4o,
11
 orthorhombic for loc3
12
) it is certainly not an artefact of crystallization. This 
dimer is also observed in the structure of the C47S mutant and is formed by the association of two molecules 
related by a crystallographic twofold axis. This association leads to the formation of a channel at the interface 
between the two molecules (Fig. 2) with the two benzoate ions obstructing both extremities of this channel. The 
benzoate ions appear as the guardians of the two gates giving access to the channel. 
What could be the exact role of the benzoate ion in the mechanism of PRDX5 remains to be elucidated. Does it 





Does it undergo a nucleophilic attack on the carboxyl carbon, as in haloperoxidases?
24
 Is it involved in a 
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completely different reaction? Or is its presence only fortuitous? This remains an open question. 
 
Fig. 2. The benzoate ion appears at the extremities of a kind of channel at the interface of two molecules of the 
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